Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis - Sorbonne Université
Article Dans Une Revue Frontiers in Molecular Neuroscience Année : 2021

Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis

Résumé

Alzheimer’s disease (AD) is the most common form of dementia. Its prevalence will significantlyincrease in the coming decades, whereas no efficient treatment is currently available. AD hastwo main neuropathological lesions: amyloid plaques and neurofibrillary tangles (NFTs). Amyloidplaques are composed of amyloid ß (Aß) peptides cleaved from the Amyloid Precursor Protein(APP) (Glenner and Wong, 1984). NFTs, present in the brain of AD and related neurodegenerativediseases, are constituted of tau proteins (Brion et al., 1985) in hyperphosphorylated and aggregatedform (Wang and Mandelkow, 2016).
Fichier principal
Vignette du fichier
fnmol-13-583755.pdf (635.96 Ko) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03136084 , version 1 (09-02-2021)

Identifiants

Citer

Kunie Ando, Sarah Houben, Mégane Homa, Marie-Ange de Fisenne, Marie-Claude Potier, et al.. Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis. Frontiers in Molecular Neuroscience, 2021, 13, ⟨10.3389/fnmol.2020.583755⟩. ⟨hal-03136084⟩
76 Consultations
45 Téléchargements

Altmetric

Partager

More